1. Home
  2. AMPH vs PCT Comparison

AMPH vs PCT Comparison

Compare AMPH & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.67

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo PureCycle Technologies Inc. Common stock

PCT

PureCycle Technologies Inc. Common stock

HOLD

Current Price

$8.77

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
PCT
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.8B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
PCT
Price
$27.67
$8.77
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$35.17
$13.67
AVG Volume (30 Days)
479.9K
4.9M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.27
N/A
Revenue
$723,305,000.00
$5,660,000.00
Revenue This Year
$0.74
N/A
Revenue Next Year
$5.63
$770.11
P/E Ratio
$12.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.39
$5.40
52 Week High
$46.11
$17.37

Technical Indicators

Market Signals
Indicator
AMPH
PCT
Relative Strength Index (RSI) 62.39 37.14
Support Level $24.92 $7.62
Resistance Level $27.83 $9.10
Average True Range (ATR) 1.20 0.63
MACD 0.21 0.07
Stochastic Oscillator 74.94 34.52

Price Performance

Historical Comparison
AMPH
PCT

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: